Search

Juliana Taliaferro Phones & Addresses

  • 906 Columbus St, Austin, TX 78704
  • Slaton, TX

Work

Company: The university of texas at austin May 2013 to Dec 2018 Position: Graduate student in medicinal chemistry

Education

Degree: Doctorates, Doctor of Philosophy School / High School: The University of Texas at Austin 2013 to 2018 Specialities: Biology, Philosophy, Chemistry

Skills

Pharmacy • Medication Therapy Management • Research • Healthcare • Immunization • Cell Culture • Public Speaking • Lifesciences • Microsoft Office • Medication Therapy Management • Molecular Biology • Pcr

Languages

Spanish

Ranks

Certificate: Acls

Industries

Hospital & Health Care

Resumes

Resumes

Juliana Taliaferro Photo 1

Pharmacist

View page
Location:
1151 Enterprise Dr, Austin, TX
Industry:
Hospital & Health Care
Work:
The University of Texas at Austin May 2013 - Dec 2018
Graduate Student In Medicinal Chemistry

Target Dec 1, 2013 - Mar 2016
Pharmacist

Heart Hospital of Austin Dec 1, 2013 - Mar 2016
Pharmacist
Education:
The University of Texas at Austin 2013 - 2018
Doctorates, Doctor of Philosophy, Biology, Philosophy, Chemistry
The University of Texas at Austin 2007 - 2013
Doctorates, Doctor of Pharmacy, Pharmacy
Skills:
Pharmacy
Medication Therapy Management
Research
Healthcare
Immunization
Cell Culture
Public Speaking
Lifesciences
Microsoft Office
Medication Therapy Management
Molecular Biology
Pcr
Languages:
Spanish
Certifications:
Acls
Medication Therapy Management

Publications

Us Patents

Indolinone Derivatives As Inhibitors Of Maternal Embryonic Leucine Zipper Kinase

View page
US Patent:
20200010455, Jan 9, 2020
Filed:
Mar 2, 2018
Appl. No.:
16/489803
Inventors:
- Austin TX, US
Ramakrishna Edupuganti - Austin TX, US
Juliana Taliaferro - Austin TX, US
Juhyeon Lee - Austin TX, US
International Classification:
C07D 403/12
C07D 405/14
C07D 401/14
C07D 413/14
C07D 209/34
Abstract:
The present disclosure relates to indolinone compounds, compositions, and methods for the inhibition of maternal embryonic leucine zipper kinase (MELK). The present disclosure further relates to indolinone compounds, compositions, and methods for the treatment or prevention of a cancer (for example, triple negative breast cancer).
Juliana Marie Taliaferro from Austin, TX, age ~35 Get Report